Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients
Objective: To investigate the efficacy of the dopamine agonist cabergoline in uncontrolled acromegaly despite long-acting somatostatin analog (SSA). Methods: Thirty-five patients with acromegaly who were followed up in the department of endocrinology and metabolism of our university were analyzed....
Saved in:
Main Authors: | Mehmet Muhittin Yalçın, Gizem Bedir Keser, Meriç Coşkun, Afruz Babayeva, Emrah Çeltikçi, Mehmet Arda İnan, Emetullah Cindil, Aylar Poyraz, Ethem Turgay Cerit, Alev Eroğlu Altınova, Müjde Aktürk, Füsun Baloş Törüner, Mehmet Ayhan Karakoç, İlhan Yetkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2024-10-01
|
Series: | Gazi Medical Journal |
Subjects: | |
Online Access: | https://gazimedj.com/articles/long-term-results-of-cabergoline-add-on-long-acting-somatostatin-analogue-therapy-in-acromegaly-patients/doi/gmj.2024.4281 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of biochemical and structural response to medical therapy in patients with active acromegaly following surgery: a real-world perspective
by: Maryam Rafieemanesh, et al.
Published: (2025-02-01) -
Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas
by: Edward Mignone, et al.
Published: (2025-01-01) -
Assessment of diabetes-specific eating disorder risk in adult patients with diabetes
by: Afruz Babayeva, et al.
Published: (2025-01-01) -
Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?
by: Çağlagül Erol, et al.
Published: (2022-08-01) -
Alterations in hippocampal somatostatin interneurons, GABAergic metabolism, and ASL perfusion in an aged male mouse model of POCD aggravated by sleep fragmentation
by: Yun Li, et al.
Published: (2024-12-01)